7.8.14 | Forbes
By Steve Brozak
At 4PM ET, the German soccer team will face Brazil in The World Cup semi-finals. The Germans might not have made it. Just a few days ago, the team could have been stopped, not by their opponent France, but by a virus that caused seven of the team’s players to come down with flu-like symptoms.
After almost a century of investigation, more than a half-century of creating seasonal vaccines, and a decade of vital U.S. Government involvement through the Biomedical Advanced Research and Development Authority (BARDA) partnering, we are still learning how flu evolves and what the future of vaccines and anti-viral medicines might look like.
That was until Dr. Yoshiro Kawaoka, a name not well known outside the flu research community, grabbed headlines. For full article, please click here.
